Elevai Labs, Inc. Common Stock
Biotechnology
Healthcare
ELAB
545 K shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
5.64
52 week high
70.00
high
5.90
52 week low
0.00
low
5.27
growth
-90.55 %
previous Close
5.63
P/E ratio
market cap
2.56 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-562.36 K
65.03 %
eps
0.00 %
84.08 %
eps surprise
0.00 %
net profit margin
-56235500.00 %
1055.00 %
operating incoming
-1.01 M
15.54 %
net change in cash
318 K
-76.94 %
cash on hand
5.68 M
5.93 %
cost of revenue
0.00 %
top top